Diagnos Inc. (ADK) Files FDA 513(g) for CARA System Classification
Diagnos Inc. submitted a Section 513(g) request to the U.S. FDA to determine classification and regulatory requirements for its CARA System, following prior FDA pre-submission.Material DetailsContext by AI AnalystThis is an early regulatory step in DIAGNOS’s push to commercialize CARA in the U.S. A…